Medindia LOGIN REGISTER
Medindia

How to Boost Tuberculosis Diagnosis in Developing Countries?

by Bidita Debnath on Sep 15 2017 12:09 AM

Early diagnosis could help curb Tuberculosis rates. But conventional methods and specialized personnel are not always available in remote or developing areas.

 How to Boost Tuberculosis Diagnosis in Developing Countries?
Tuberculosis - or TB, as it’s commonly called - is a contagious infection that usually attacks the lungs. It can also spread to other parts of the body, like the brain and spine. Diagnosing TB early can allow patients to receive the medicine they need and also help prevent the disease from spreading.
But in resource-limited areas, equipment requirements and long wait times for results are obstacles to diagnosis and treatment. To tackle this problem, scientists report in ACS Sensors the development of a fast, paper-based tuberculosis test that can be read with a smartphone.

The World Health Organization estimates that in 2015, 1.4 million people died from TB, with most of these deaths occurring in low- and middle-income countries. Early diagnosis could help curb these numbers. But conventional methods such as sputum smear microscopy, chest X-rays and molecular-based tests require equipment, electricity and specialized personnel that are not always available in remote or developing areas.

So Chien-Fu Chen and colleagues set out to come up with a more practical diagnostic test that can be read with a smartphone, a technology that is increasingly available in emerging economies.

The researchers combined gold nanoparticles with single-stranded DNA sequences that bind to the genetic material of Mycobacterium tuberculosis, the bacteria that cause TB. These nanoparticles were then incorporated into a paper-based device.

Adding even a minute amount of lab-derived, double-stranded DNA from M. tuberculosis changed the color of the test spots within an hour. A smartphone camera was used to analyze the color change to determine the bacterial concentration. The researchers also tested a tissue sample from an infected patient to further demonstrate that the device could be used in the field.

Source-Eurekalert


Advertisement